These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21188830)

  • 1. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.
    Kobori H; Fu Q; Crowley SD; Gonzalez-Villalobos RA; Campos RR
    J Appl Physiol (1985); 2010 Dec; 109(6):2003. PubMed ID: 21148352
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Regulation by the Arcuate Nucleus of the Hypothalamus: Neurocircuitry and Signaling Systems.
    Rahmouni K
    Hypertension; 2016 Jun; 67(6):1064-71. PubMed ID: 27045026
    [No Abstract]   [Full Text] [Related]  

  • 3. Sympathetic nervous activation and hypertension.
    Hoshide S; Mogi M; Kario K
    Hypertens Res; 2023 Jul; 46(7):1636-1637. PubMed ID: 37402815
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on the management of hypertension.
    LaPLACE LB
    Del State Med J; 1950 Oct; 22(10):283-91. PubMed ID: 14778320
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic activation is the dominant contributor to systemic hypertension.
    Fu Q; Levine BD
    J Appl Physiol (1985); 2010 Dec; 109(6):2012. PubMed ID: 21188802
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Obesity: a common prime mover of chronic activation of the sympathetic nervous system and the renin-angiotensin system in systemic hypertension?
    Szelényi Z
    J Appl Physiol (1985); 2010 Dec; 109(6):2008-9. PubMed ID: 21188835
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Negrao CE; Negrao MV
    J Appl Physiol (1985); 2010 Dec; 109(6):2006. PubMed ID: 21188817
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Goldstein DS
    J Appl Physiol (1985); 2010 Dec; 109(6):2005-6. PubMed ID: 21188816
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. The dominant mechanism depends on individual circumstance.
    Mathai ML
    J Appl Physiol (1985); 2010 Dec; 109(6):2011. PubMed ID: 21188826
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic activation: cause or consequence of hypertension?
    Campos RR; Bergamaschi CT
    J Appl Physiol (1985); 2010 Dec; 109(6):2013-4. PubMed ID: 21188830
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions between the sympathetic nervous system and angiotensin system in renovascular hypertension.
    Pradhan N; Rossi NF
    Curr Hypertens Rev; 2013 May; 9(2):121-9. PubMed ID: 23971694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II and vascular damage in hypertension: Role of oxidative stress and sympathetic activation.
    Masi S; Uliana M; Virdis A
    Vascul Pharmacol; 2019 Apr; 115():13-17. PubMed ID: 30707954
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.